首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >The Effect of a 12-Week Omega-3 Supplementation on Body Composition Muscle Strength and Physical Performance in Elderly Individuals with Decreased Muscle Mass
【2h】

The Effect of a 12-Week Omega-3 Supplementation on Body Composition Muscle Strength and Physical Performance in Elderly Individuals with Decreased Muscle Mass

机译:补充12周的Omega-3对肌肉量减少的老年人的身体成分肌肉力量和身体机能的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the study was to assess the effect of a polyunsaturated omega-3 fatty acids (PUFA) supplementation on the parameters of body composition, muscle strength and physical performance in elderly people with decreased muscle mass (DMM). Fifty three elderly people with an ALM index (the ratio of appendicular lean mass to squared height) either below (−2SD: low muscle mass-LMM) or between (−1SD and −2SD: the risk of LMM-rLMM) the ALM index for the young Polish reference population were randomly assigned to PUFA-treated groups (LMM-PUFA, rLMM-PUFA) or control groups (LMM-control, rLMM-control). PUFA-treated groups received capsules containing 1.3 g of PUFA and 10 mg of vitamin E, while the control groups received 11 mg of vitamin E daily for 12 weeks. Body composition (BIA analysis), muscle strength (hand grip measured with dynamometer) and physical performance (Timed Up and Go test-TUG) were assessed before and after supplementation. No statistically significant differences were observed either in muscle mass or in the hand grip and TUG in any group. The post-pre difference (mean ± SD) in ALM index was as follows (kg/m2): LMM-PUFA: 0.00 ± 0.30, rLMM-PUFA: 0.00 ± 0.22, LMM-control: 0.03 ± 0.36, rLMM-control: –0.03 ± 0.20. In our study, a 12 week supplementation of PUFA did not affect the evaluated parameters in elderly individuals with DMM.
机译:这项研究的目的是评估补充多不饱和omega-3脂肪酸(PUFA)对肌肉量减少(DMM)的老年人的身体成分,肌肉力量和身体机能参数的影响。 53名ALM指数低于(-2SD:低肌肉质量LMM)或介于(-1SD和-2SD:LMM-rLMM风险)之间的ALM指标(阑尾瘦体重与身高的平方比)波兰的年轻参考人群被随机分为PUFA治疗组(LMM-PUFA,rLMM-PUFA)或对照组(LMM-对照组,rLMM-对照组)。 PUFA治疗组接受的胶囊含有1.3 g PUFA和10 mg维生素E,而对照组则每天接受11 mg维生素E,持续12周。在补充之前和之后评估身体成分(BIA分析),肌肉力量(用测力计测量的握力)和身体表现(Timed Up and Go test-TUG)。在任何一组中,无论是肌肉质量还是手部握力和TUG均未观察到统计学上的显着差异。 ALM指标的事后差异(平均值±SD)如下(kg / m 2 ):LMM-PUFA:0.00±0.30,rLMM-PUFA:0.00±0.22,LMM-control: 0.03±0.36,rLMM控制:–0.03±0.20。在我们的研究中,补充PUFA 12周不会影响DMM老年患者的评估参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号